Zdrowie i gospodarka · 21/07/2022
FDA Announces Draft Guidance for Dose Banding in Prescription Drug Labeling
The FDA is releasing a draft guidance to help pharmaceutical companies incorporate dose banding information into the labeling of new prescription drugs, particularly those packaged in ready-to-use containers with varying strengths.
Source: Federal Register — Food and Drug AdministrationOpen original release →